Brexit - implications for therapeutic goods in Australia

TGA

25 February 2020 - A transition period is in effect until the end of 2020 while the UK and EU negotiate additional arrangements. 

The current rules, including those for therapeutic goods, for the UK and EU will continue to apply during the transition period.

There will be no impact on the supply of medicines to Australia from the UK during the transition period. The UK remains in the EU single market and is subject to EU rules and regulations. 

The existing EU-Australia MRA remains in force for the UK until the transition period ends.

Read TGA News


Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Australia , Supply , Brexit